Continuing the Conversation: Seeing Improvements in the Management of Age-Related Macular Degeneration and Diabetic Macular Edema With Pharmacist Involvement

Continuing the Conversation: Seeing Improvements in the Management of Age-Related Macular Degeneration and Diabetic Macular Edema With Pharmacist Involvement is organized by Pharmacy Times Continuing Education (PTCE).,Release date: October 1, 2022,Expiration date: October 1, 2023,Description:,This activity includes expert insight and responses to commonly asked questions regarding the management of age-related macular degeneration and diabetic macular edema with emerging anti-vascular endothelial growth factor and angiopoietin-2 therapies. Practical strategies for pharmacists to reduce rates of vision loss in age-related macular degeneration and diabetic macular edema by improving adherence to therapy will be discussed.,,Educational Objectives:,At the completion of this activity, participants will be able to:,• Identify commonly asked questions regarding the management of age-related macular degeneration (AMD), diabetic macular edema (DME), and individualized care,• Analyze safety, efficacy data, and clinical evidence for the use of current and emerging therapies in the management of AMD and DME,• Illustrate best practices for the pharmacist in the management of AMD and DME